Multicentre open-label randomised controlled trial comparing the efficacy and safety of colistin-based combination therapy with the best available therapy for treating hospital-acquired pneumonia or bloodstream infections caused by carbapenem-resistant Enterobacteriaceae (COUNT-CRE): a study protocol
Introduction The prevalence of carbapenem-resistant Enterobacteriaceae (CRE) infections is increasing worldwide. However, the evidence regarding the treatment of infections caused by CRE is either low or conditional.Methods and analysis This multicentre, investigator-initiated, open-label, randomise...
Saved in:
Main Authors: | Tao Chen, Chen Zhang, Jianfeng Xie, Yingzi Huang, Xiangquan Li, Jiaqiong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-07-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/15/7/e092157.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carbapenem-Resistant Enterobacteriaceae (CRE) in Children with Cancer: The Impact of Rapid Diagnostics and Targeted Colonization Strategies on Improving Outcomes
by: Youssef Madney, et al.
Published: (2025-07-01) -
Effect of Differences in the CLSI and EUCAST Criteria on the Interpretation of Enterobacteriaceae Sensitivity to Carbapenems
by: L. A. Kornoukhova, et al.
Published: (2021-10-01) -
Comparison of Carbapenem vs. Amikacin Antimicrobial Therapy for Pediatric Acute Pyelonephritis Caused by Extended-Spectrum Β-Lactamase-Positive Enterobacteriaceae
by: Burcu Ceylan Cura Yayla, et al.
Published: (2025-07-01) -
Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-Analysis.
by: Myrto Eleni Flokas, et al.
Published: (2017-01-01) -
An analysis of risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Klebsiella pneumoniae
by: ZHU Qiuli, et al.
Published: (2025-04-01)